CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content


Last Updated: October 10, 2006
Result type: Reports
Project Number: S0080
Product Line: Common Drug Review

Generic Name: Alglucosidase

Brand Name: Myozyme

Manufacturer: Genzyme Canada Inc.

Indications: Pompe’s disease

Submission Type: New

Project Status: Complete

Date Recommendation Issued: June 14, 2007

Recommendation Type: List with clinical criteria and/or conditions